Optimer Pharmaceuticals, Inc. - OPTR - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Optimer Pharmaceuticals, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
OPTR	Nasdaq	8731	http://www.optimerpharma.com	14.70 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Optimer Pharmaceuticals, Inc. Nasdaq stocks posting largest percentage increases - May 20th, 2013 4:05 pm OPTIMER PHARMACEUTICALS INC Financials - May 17th, 2013 11:04 am MARKET PULSE-Cisco, Wal-Mart, Kohl's, Tesla, AMD, SunPower, Oncothyreon - May 16th, 2013 6:46 am Cubist bid for Optimer before sale process began-sources - May 15th, 2013 3:19 pm Cubist bid for Optimer before sale process began-sources - May 15th, 2013 3:19 pm Cubist bid almost $1 billion for Optimer before sale process: sources - May 15th, 2013 2:08 pm Cubist bid almost $1 bln for Optimer before sale process-sources - May 15th, 2013 1:47 pm Cubist bid almost $1 bln for Optimer before sale process-sources - May 15th, 2013 1:47 pm Is AstraZeneca Gearing Up for a Shopping Spree? - May 15th, 2013 8:08 am Markman Hearing A Likely Clearing Event For Cubist - Decision Any Day - May 14th, 2013 8:23 am Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says - May 13th, 2013 2:53 pm AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer - May 13th, 2013 2:11 pm Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer - May 13th, 2013 2:04 pm 3 Biotech Stocks Spiking With Big Volume - May 13th, 2013 1:06 pm OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr - May 13th, 2013 8:13 am Investors are Digesting These Healthcare Stock Earnings Insights - May 12th, 2013 9:55 am The Best- And Worst-Performing Biotech Stocks, May 3 To May 10 - May 11th, 2013 8:07 am Optimer Pharmaceuticals Misses on the Top and Bottom Lines - May 10th, 2013 4:10 pm Why Optimer Pharmaceuticals Shares Sank - May 10th, 2013 11:48 am Wider-than-Expected Loss at Optimer - May 10th, 2013 9:40 am View All Current Headlines >>